Proposed changes could reduce access to prescription drugs
While well-intentioned, changes to Patented Medicine Prices Review Board could stop companies from launching new drugs
Read MoreWhile well-intentioned, changes to Patented Medicine Prices Review Board could stop companies from launching new drugs
Read MoreThe consistent lengthening of wait times for treatment makes us sometimes forget our system forces people to suffer while waiting for timely access to care
Read MoreThe Canadian Institute for Health Information annual tracking of waits for priority procedures is a reminder of how little has changed and how far we have to go
Read MoreTo retain the promise of universal healthcare that Canadians cherish, we must change the way we attempt to deliver it
Read MoreWait times have become the defining characteristic of our health system, but still we argue about methodology rather than seeking solutions
Read More